CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

Related Keywords

Wuxi ,Jiangsu ,China ,United States ,Beijing ,Rui Zhang ,Pharmaceuticals Inc ,Acrotech Biopharma Inc ,National Medical Products Administration ,Pharmaceuticals China Co Ltd ,Drug Administration ,Exchange Commission ,Mundipharma Medical Company ,Juventas Biotechnology Tianjin Co Ltd ,Mundipharma International Corporation ,Nasdaq ,Chief Executive Officer ,Juventas Biotechnology ,Drug Application ,Cleave Therapeutics ,Mundipharma International Corporation Limited ,Incentive Plan ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Acrotech Biopharma ,Condensed Consolidated Statements ,